Leslie Kiloh [1917-1997] was a British psychiatrist, well known for his studies in the classification of depressive disorders and the EEG. In 1962, he became the chair of psychiatry at the new Medical School at the University of New South Wales in Australia – a position he held for 20 years until retiring. He studied […]
“The time has come," the Walrus said, “To talk of many things: Of shoes··and ships··and sealing-wax·· Of cabbages··and kings·· And why the sea is boiling hot·· And whether pigs have wings.” The Walrus and the Carpenter Lewis Carroll, 1832 – 1898 It seems like only yesterday, but it’s been three years since the DSM-5 was […]
NIH study shows almost 10 million US adults misusing prescription opioids in 2012-2013 PHARMABIZ.COM June 24, 2016 Nonmedical use of prescription opioids more than doubled among adults in the United States from 2001-2002 to 2012-2013, based on a study from the National Institute on Alcohol Abuse and Alcoholism [NIAAA], part of the National Institutes of […]
With the Paxil Study 329 paper, our problem getting it in print didn’t have to do with journal shopping, it had to do with a tough love review process and a year of uncertainty that went with it. It was a top journal [British Medical Journal Impact Factor 17.445] and I’m glad it’s there. The […]
When I retired a lot of people kept asking me what I was going to do. Their questions made me aware that I had no idea, so I made up something. "I want to find my inner boredom" I would say. Later, I found a more accurate answer, "I want to think about what I […]
It may seem peculiar, but it makes sense to me. As a young guy in medicine, I was pulled in two directions – research into things we don’t yet know, and the application of things we do know. The former was where my mind naturally headed, but the latter was what gave me a sense […]
Dr. Insel’s selection as Director of the NIMH in 2002 was a surprise choice. After losing his position in the NIMH Intramural program, he came to Atlanta to head the Yerkes Primate Center. After one term, he was not reappointed [the scuttle-but – too controlling] and then became Director of a Translational Center, a research […]
The American Psychiatric Association Preliminary Scientific Program for the Annual Meeting is on-line, and I was perusing it looking for something specific. I remain awed that the Harvard Master Class Psychopharmacology Course still has veterans from Chuck Grassley’s Senate Investigation [see april fools day – 2016…]. So I was curious to see if they were […]
In Dr. Fava’s editorial from the last post [what can be done…], he wrote: The Inadequacy of EBM Recently, Richardson and Doster suggested the consideration of three dimensions in the process of evidence-based decision: baseline risk of poor outcomes from an index disorder without treatment responsiveness to the treatment option vulnerability to the adverse effects […]
Editorial US Preventive Services Task Force Recommendation Statement on Screening for Depression in Adults Not Good Enough by Charles F. Reynolds III, MD and Ellen Frank, PhD JAMA Psychiatry. 2016 73[3]:189-190. The US Preventive Services Task Force [USPSTF] has recommended screening for depression in the general adult population, including pregnant and postpartum women, with the […]